VTE risk and family history: Provocative findings

Blood

Volumn 124, Issue 13, 2014, Pages 2011-

  Garcia, David A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTEIN C; PROTEIN S;

ANTICOAGULANT THERAPY; ENVIRONMENTAL FACTOR; FAMILY HISTORY; HOSPITALIZATION; HUMAN; RECURRENT DISEASE; REVIEW; RISK FACTOR; TREATMENT DURATION; VENOUS THROMBOEMBOLISM; FAMILY; FEMALE; MALE;

FAMILY; FEMALE; HUMANS; MALE; VENOUS THROMBOEMBOLISM;

EID: 84907276429     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-08-592535     Document Type: Review

References (4)

1. Couturaud F, Leroyer C, Tromeur C, et al. Factors that predict thrombosis in relatives of patients with venous thromboembolism. Blood. 2014; 124(13):2124-2130.
2. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet. 1999; 353(9159):1167-1173.
3. Demers C, Ginsberg JS, Hirsh J, Henderson P, Blajchman MA. Thrombosis in antithrombin-III-deficient persons. Report of a large kindred and literature review. Ann Intern Med. 1992; 116(9):754-761.
4. Lijfering WM, Brouwer JL, Veeger NJ, et al. Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood. 2009; 113(21):5314-5322.